Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer
Madeleine Dorsch, Felix E.G. Beaudry, Anna K. Baginska, Nancy Meyer, Anne Petzold, Peihua Zhao, Belen Otero-Carrasco, Kazeera Aliar, Sebastian Urban, Julia Zummack, Jiwon Jung, Johanna Maria Hölken, Ningjun Duan, Laura Godfrey, Mei-Ju May Chen, , Barbara M. Grüner
This study identifies LOY as a driver of aggressive PDAC through epigenetic reprogramming, linking it to EMT and metastasis, and highlights its clinical relevance as a biomarker.
bioRxiv · Oct 8, 2026 · PreprintCancer Biology